LU75698A1 - - Google Patents
Info
- Publication number
- LU75698A1 LU75698A1 LU75698A LU75698A LU75698A1 LU 75698 A1 LU75698 A1 LU 75698A1 LU 75698 A LU75698 A LU 75698A LU 75698 A LU75698 A LU 75698A LU 75698 A1 LU75698 A1 LU 75698A1
- Authority
- LU
- Luxembourg
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
- C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7526859A FR2322606A1 (fr) | 1975-09-02 | 1975-09-02 | Nouveaux 2,2-dimethyl steroides, leur procede de preparation et leur application comme medicament |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU75698A1 true LU75698A1 (en:Method) | 1977-06-15 |
Family
ID=9159543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU75698A LU75698A1 (en:Method) | 1975-09-02 | 1976-09-01 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4078059A (en:Method) |
| JP (1) | JPS5233663A (en:Method) |
| BE (1) | BE845740A (en:Method) |
| CA (1) | CA1072540A (en:Method) |
| CH (1) | CH614722A5 (en:Method) |
| DE (1) | DE2639600A1 (en:Method) |
| DK (1) | DK140847B (en:Method) |
| FR (1) | FR2322606A1 (en:Method) |
| GB (1) | GB1518864A (en:Method) |
| IE (1) | IE44385B1 (en:Method) |
| LU (1) | LU75698A1 (en:Method) |
| NL (1) | NL7609690A (en:Method) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2364655A1 (fr) * | 1976-09-17 | 1978-04-14 | Roussel Uclaf | Nouveaux 2,2-dimethyl 19-nor steroides, leur procede de preparation et leur application comme medicament |
| FR2434175A1 (fr) * | 1978-03-15 | 1980-03-21 | Roussel Uclaf | Nouveaux 2,2-dimethyl 19-nor steroides, leur procede de preparation et leur application comme medicaments |
| FR2444047A1 (fr) * | 1978-12-13 | 1980-07-11 | Roussel Uclaf | Nouveaux derives 2,2-dimethyl 19-nor steroides, leur procede de preparation et leur application comme medicaments |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB803777A (en) * | 1955-11-16 | 1958-10-29 | Upjohn Co | Improvements in or relating to steroids and the manufacture thereof |
-
1975
- 1975-09-02 FR FR7526859A patent/FR2322606A1/fr active Granted
-
1976
- 1976-08-31 US US05/719,138 patent/US4078059A/en not_active Expired - Lifetime
- 1976-08-31 NL NL7609690A patent/NL7609690A/xx not_active Application Discontinuation
- 1976-09-01 BE BE170262A patent/BE845740A/xx not_active IP Right Cessation
- 1976-09-01 DK DK394576AA patent/DK140847B/da not_active IP Right Cessation
- 1976-09-01 CA CA260,309A patent/CA1072540A/fr not_active Expired
- 1976-09-01 LU LU75698A patent/LU75698A1/xx unknown
- 1976-09-02 GB GB36342/76A patent/GB1518864A/en not_active Expired
- 1976-09-02 DE DE19762639600 patent/DE2639600A1/de not_active Withdrawn
- 1976-09-02 IE IE1959/76A patent/IE44385B1/en unknown
- 1976-09-02 JP JP51104363A patent/JPS5233663A/ja active Pending
- 1976-09-02 CH CH1115976A patent/CH614722A5/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IE44385B1 (en) | 1981-11-04 |
| NL7609690A (nl) | 1977-03-04 |
| CH614722A5 (en:Method) | 1979-12-14 |
| IE44385L (en) | 1977-03-02 |
| JPS5233663A (en) | 1977-03-14 |
| DK140847C (en:Method) | 1980-05-12 |
| GB1518864A (en) | 1978-07-26 |
| DE2639600A1 (de) | 1977-03-03 |
| FR2322606B1 (en:Method) | 1979-09-14 |
| BE845740A (fr) | 1977-03-01 |
| US4078059A (en) | 1978-03-07 |
| DK394576A (en:Method) | 1977-03-03 |
| FR2322606A1 (fr) | 1977-04-01 |
| CA1072540A (fr) | 1980-02-26 |
| DK140847B (da) | 1979-11-26 |